We might earn a commission if you make a purchase through one of the links. McClatchy's Commerce Content team, which is independent from our newsroom, oversees this content. This content is only ...

PASADENA, Calif.--(BUSINESS WIRE)--Men who take Viagra, Cialis or Levitra and other drugs of the same class for erectile dysfunction (ED) experience lower rates of heart failure and death due to heart ...

Small concentrations of it dissolved in a vase of water can double the shelf life of cut flowers, researchers have found. The droop-delaying substance is sildenafil, sold under the brand name Viagra - ...

Oct. 23 -- THURSDAY, Oct. 22 (HealthDay News) -- Doctors should prescribe oral phosphodiesterase type 5 (PDE-5) inhibitor drugs, such as Viagra, Cialis and Levitra, for men with erectile dysfunction, ...

In an effort to reduce treatment stigma, telemedicine company Hims & Hers is compounding prescriptions for erectile dysfunction and turning them into wintergreen-flavored chewables. The “Hard Mints” ...

The widely used erectile dysfunction drug Levitra is now the second drug in its class found to protect the heart against tissue damage following acute heart attack, according to a new study by ...

Viagra, Levitra and Cialis typically treat men who suffer from erectile dysfunction (ED), but a new Swedish study says these ED drugs may also help prolong the lives of men diagnosed with colon cancer ...

Phosphodiesterase type 5 inhibitors (PDE5i)—an erectile dysfunction drug sold under the names Viagra, Levitra, Cialis, and others—are a common medical treatment for erectile dysfunction (ED) in men ...

It comes in several buy levitra vardenafil doses and is taken as-needed. If you have any complications buy levitra vardenafil questions about your health, please note to a certain. It hair in four ...

SAN DIEGO, March 31, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI), announced today that the Mexican Patent Office ("MPO") will grant an additional patent for ...

SAN DIEGO, April 28, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI) announced today that it has filed a marketing application in Europe for Vitaros ® as a treatment ...